Sections
Edition
Language
Society
Health

Hipra is participating in a European consortium to create an intranasal flu vaccine

Unverified translation
A Hipra employee conducting research in the company's laboratories.
A Hipra employee conducting research in the company's laboratories. Imatge cedida a l'ACN per Hipra
1 min

Hipra will participate in a European consortium to research and produce an intranasal flu vaccine. The goal is to create a vaccine with broader and longer-lasting protection that doesn't focus solely on seasonal strains, as is the case with the versions currently available on the market.

stats